Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|December 17, 2018
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trialMitsukuni Suenaga, Sebastian Stintzing, Shu Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2016
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based ChemotherapySatoshi Matsusaka, Diana L Hanna, Shu Cao, et al.
Cancers|October 17, 2020
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer PatientsNico B Volz, Diana L Hanna, Sebastian Stintzing, et al.
The Pharmacogenomics Journal|February 5, 2021
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancerMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Molecular Cancer Therapeutics|March 18, 2016
TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based ChemotherapySatoshi Matsusaka, Wu Zhang, Shu Cao, et al.
Scientific Reports|June 29, 2023
Modified ulnar lengthening for correction of the Masada type 2 forearm deformity in hereditary multiple exostosisShu Cao, Jian-Fa Zeng, Sheng Xiao, et al.
Cancers|July 8, 2020
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE TrialMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2022
Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspectiveChrysanthi Skevaki, R Sharon Chinthrajah, Daria Fomina, et al.
Journal of Translational Medicine|March 1, 2017
Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathwayMing-de Zang, Lei Hu, Zhi-Yuan Fan, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Pageof 16